Literature DB >> 3470269

Multiple dosing of prostaglandin F2 alpha or epinephrine on cynomolgus monkey eyes. I. Aqueous humor dynamics.

C B Camras, S M Podos, J S Rosenthal, P Y Lee, C H Severin.   

Abstract

After obtaining baseline intraocular pressure (IOP) measurements for 1 week, prostaglandin (PG) F2 alpha (250 micrograms in 50 microliters saline) or epinephrine 2% solution (50 microliters) was topically applied twice daily for 2 weeks to one eye of six cynomolgus monkeys for each agent tested. Contralateral control eyes received their respective vehicles. PGF2 alpha significantly reduced IOP beginning 2 to 3 hr after the first dose, persisting thereafter. A significant (P less than 0.05) hypotensive effect remained for at least 10 hr after the first dose and at least 14 hr after the sixth dose. At 4 hr after the seventh dose, the mean reduction was 10.2 +/- 3.5 (+/- SD) mmHg below baseline (P less than 0.0025). At this time, there was also a significant (P less than 0.01) mean reduction of IOP in the contralateral vehicle-treated eyes of 6.0 +/- 3.3 (+/- SD) mmHg below baseline, which did not appear to be secondary to diurnal fluctuations, repeated tonometry, experimental manipulation, or inadvertent drug transfer. Epinephrine significantly (P less than 0.05) reduced IOP beginning 3 hr after the first dose, but this reduction was minimal and not consistent. Neither PGF2 alpha nor epinephrine altered aqueous flow as measured by fluorophotometry 2 to 6 hr after the fifth dose. Outflow facility could not be assessed by indentation tonography because IOP was often too low at the time of measurement. Whereas PGF2 alpha did not alter pupil size, epinephrine caused significant pupillary dilation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3470269

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Experimental Tibetan monkey domestication and its application for intraocular pressure measurement.

Authors:  Yong Yi; Tao Zeng; Liang Zhou; Su-Ping Cai; Yan Yin; Yun Wang; Xu Cao; Yue-Zhong Xu; Hong-Xing Wang; Xu-Yang Liu
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

2.  Prostaglandin F2 alpha-isopropylester eye drops: effect on intraocular pressure in open-angle glaucoma.

Authors:  J Villumsen; A Alm; M Söderström
Journal:  Br J Ophthalmol       Date:  1989-12       Impact factor: 4.638

3.  The role of prostaglandins in the para-aminoclonidine-induced reduction of intraocular pressure.

Authors:  R F Wang; C B Camras; S M Podos; K W Lee; K C Bhuyan; D K Bhuyan
Journal:  Trans Am Ophthalmol Soc       Date:  1989

4.  Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes.

Authors:  J Villumsen; A Alm
Journal:  Br J Ophthalmol       Date:  1989-06       Impact factor: 4.638

5.  The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study.

Authors:  Sven Dinslage; Arno Hueber; Michael Diestelhorst; Günther Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08       Impact factor: 3.117

6.  Localisation of prostaglandin F2 alpha and E2 binding sites in the human eye.

Authors:  T Matsuo; M S Cynader
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

7.  Characterization of intraocular pressure responses of the Tibetan monkey (Macaca thibetana).

Authors:  Guo Liu; Tao Zeng; Wenhan Yu; Naihong Yan; Hongxing Wang; Su-ping Cai; Iok-Hou Pang; Xuyang Liu
Journal:  Mol Vis       Date:  2011-05-27       Impact factor: 2.367

8.  Posture-Dependent 24-Hour Intraocular Pressure Fluctuation Patterns in an Intraocular Hypertension Monkey Model.

Authors:  Shu Tu; Kang Li; Dongpeng Hu; Kaijing Li; Jian Ge
Journal:  Transl Vis Sci Technol       Date:  2019-06-28       Impact factor: 3.283

9.  Evaluation of monkey intraocular pressure by rebound tonometer.

Authors:  Wenhan Yu; Guiqun Cao; Jinghua Qiu; Xuyang Liu; Jia Ma; Ni Li; Man Yu; Naihong Yan; Lei Chen; Iok-Hou Pang
Journal:  Mol Vis       Date:  2009-10-27       Impact factor: 2.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.